The peptide enters circulation directly, bypassing digestive processes that can reduce effective doses even for stable compounds
Iron deficiency causes koilonychia (spoon-shaped nails), brittleness, pallor, and slow growth in severe cases
Peptide therapy with prescribed compounds like tesamorelin or sermorelin (in some contexts) involves legitimate pharmaceutical products
These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying
Also, seek help if side effects interfere with your daily life or do not improve over time